AI Chat
Macro & News
Stocks
Alpha Lab
Utility
Menu
EN
Login
EN
Surge Analysis
/
Telcon RF Pharmaceutical Inc.
/
2026-04-14
▲ SURGE
Telcon RF Pharmaceutical Inc.
+25.0%
200230
KRX
Healthcare
2026-04-14
780
Close
624
Prev Close
+25.00%
Change
22.2x
Vol Ratio
Why It Surged
제공된 뉴스 기사 내에 Telcon RF Pharmaceutical Inc.(200230)와 관련된 구체적인 정보나 핵심 팩트가 포함되어 있지 않습니다.
·
제공된 뉴스 기사 내에 Telcon RF Pharmaceutical Inc.(200230)와 관련된 구체적인 정보나 핵심 팩트가 포함되어 있지 않습니다.
Related News
Regeneron Gets FDA OK for Extended Eylea HD Dosing
Marketwatch
2026-04-02
에이프릴바이오, 임상 결과 전 내부자 매도…셀비온·뉴로핏은 강세[바...
edaily
2026-02-13
Telix and Regeneron Strike Global Radiopharma Alliance in Precision Oncology Push
Tipranks
2026-04-12
NovoCure Says FDA Approves NovoCure's Optune Pax For Treatment Of Locally Advanced Pancreatic Cancer - NovoCure (NASDAQ:NVCR)
Benzinga
2026-02-11
HC Wainwright & Co. Reiterates Buy on Telix Pharmaceuticals, Maintains $20 Price Target - Telix Pharmaceu
Benzinga
2026-04-13
Technical Analysis
Signals
MACD Bearish
Below SMA20
Key Indicators
50.44
RSI (14)
785.30
SMA 20
610.38
Bollinger Lower
960.22
Bollinger Upper
785.30
Bollinger Mid
-34.73
MACD
-21.50
MACD Signal
-13.23
MACD Hist
View Company
Back to Surge Stocks
Telcon RF Pharmaceutical Inc. Surged +25.0% on 2026-04-14 — Analysis | Alpha Lenz